Drug Trial Radar · NCT05361174
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
53
Planned (sponsor's estimate)
Start
Jul 20, 2022
Primary completion
Sep 2027
Study completion Sep 2029
Sponsor
- Lead sponsor
- Iovance Biotherapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 4, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC).
Conditions
- Unresectable Melanoma
- Metastatic Melanoma
- Stage III Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer
Interventions
IOV-4001Biological
A tumor sample is resected from each participant and cultured ex-vivo to manufacture IOV-4001. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, participant is infused with IOV-4001, and followed by IL-2.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: Safety of IOV-4001Time frame: Up to 1 Year or depending on when the recommended phase 2 dose is determined
- Phase 2: Objective Response Rate (ORR)Time frame: Up to 60 months
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
The Angeles Clinic and Research Institute
Los Angeles, California · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Orlando Health Cancer Institute
Orlando, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
The University of Kansas Cancer Center
Westwood, Kansas · Recruiting
University of Louisville
Louisville, Kentucky · Recruiting
Weill Medical College of Cornell University
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin · Withdrawn
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.